Clinical Trial Update: Efficacy of KL1333 in Adult Patients With Primary Mitochondrial Disease [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial evaluating KL1333 in adults with primary mitochondrial disease is currently recruiting. Sponsor Abliva AB.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Mitochondrial Disease

Drugs mentioned

• KL1333

Snippet

Sponsor: Abliva AB | Conditions: Primary Mitochondrial Disease | Phase 2 | Status: RECRUITING